TITLE

Plant sterol-enriched spread enhances the cholesterol-lowering potential of a fat-reduced diet

AUTHOR(S)
Cleghorn, C L; Skeaff, C M; Mann, J; Chisholm, A
PUB. DATE
January 2003
SOURCE
European Journal of Clinical Nutrition;Jan2003, Vol. 57 Issue 1, p170
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE:: To determine the effect of a plant sterol-enriched spread on plasma cholesterol concentrations when replacing butter or a standard polyunsaturated spread in a diet containing 30% of energy fat. DESIGN:: Parallel butter phase followed by double-blind, randomized, cross-over polyunsaturated spread phases. SETTING:: General community. SUBJECTS:: Volunteer sample of 50 free-living men and women with mean age (s.d.) 46.7 y (10.5), moderately elevated plasma total cholesterol 5.95 mmol/l (0.78), and body mass index 26.0 (3.9) kg/m2. INTERVENTION:: Participants ate a moderately low-fat diet (30% of energy) for the 11-week intervention. During the first 3 weeks the diet included 20 g per day of butter. Participants were then randomized to replace the butter with 25 g of polyunsaturated spread with or without 2 g of plant sterols for 4 weeks, crossing over in the last 4 weeks to the alternate spread. MAIN OUTCOME MEASURES:: Plasma cholesterol and fatty acids. RESULTS:: Replacing butter with a standard polyunsaturated fat spread reduced mean plasma total cholesterol concentrations by 4.6% (from 6.09 (0.82) to 5.81 (0.77) mmol/l, P<0.01) and low-density lipoprotein cholesterol by 5.5% (from 3.98 (0.76) to 3.76 (0.74) mmol/l, P<0.05). Replacing butter with a polyunsaturated spread containing plant sterols reduced plasma total cholesterol by 8.9% (from 6.09 (0.82) to 5.55 (0.76) mmol/l, P<0.01) and low density lipoprotein cholesterol by 12.3% (from 3.98 (0.76) to 3.49 (0.72) mmol/l, P<0.01). Plasma high density lipoprotein cholesterol concentration was the same on the three diets. CONCLUSION:: In people with moderately raised plasma cholesterol concentrations consuming reduced-fat diets the reduction in plasma total and low-density lipoprotein cholesterol concentrations achieved by replacing butter with a polyunsaturated spread is enhanced by addition of plant sterols. SPONSORSHIP:: Partially funded by a grant to the University of Otago from Unilever...
ACCESSION #
8974070

 

Related Articles

  • Efficacy and Safety of Plant Stanols and Sterols in the Management of Blood Cholesterol Levels. Katan, Martijn B.; Grundy, Scott M.; Jones, Peter; Law, Malcolm; Miettinen, Tatu; Paoletti, Rodolfo // Mayo Clinic Proceedings;Aug2003, Vol. 78 Issue 8, p965 

    Foods with plant stanol or sterol esters lower serum cholesterol levels. We summarize the deliberations of 32 experts on the efficacy and safety of sterols and stanols. A meta-analysis of 41 trials showed that intake of 2 g/d of stanols or sterols reduced low-density lipoprotein (LDL) by 10%;...

  • Plant sterols: factors affecting their efficacy and safety as functional food ingredients. Berger, Alvin; Jones, Peter J. H.; Abumweis, Suhad S. // Lipids in Health & Disease;2004, Vol. 3, p5 

    Plant sterols are naturally occurring molecules that humanity has evolved with. Herein, we have critically evaluated recent literature pertaining to the myriad of factors affecting efficacy and safety of plant sterols in free and esterified forms. We conclude that properly solubilized 4-desmetyl...

  • NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe. Hegele, Robert A.; Guy, Justin; Ban, Matthew R.; Wang, Jian // Lipids in Health & Disease;2005, Vol. 4, p1 

    Background: NPC1L1 encodes a putative intestinal sterol transporter which is the likely target for ezetimibe, a new type of lipid-lowering medication. We previously reported rare non-synonymous mutations in NPC1L1 in an individual who had no plasma lipoprotein response to ezetimibe. We next...

  • To benefit from low-fat diet, add exercise.  // Environmental Nutrition;Aug98, Vol. 21 Issue 8, p1 

    States that according to research, exercise and low-fat diets reduced low-density lipoprotein cholesterol. Details on a study which was conducted; Results of the study.

  • LDL size determines the response to low-fat diet in selected patients.  // Modern Medicine;Sep96, Vol. 64 Issue 9, p23 

    Reports on the result of the study about the effects of low-fat diet on the level of low-density lipoprotein (LDL) cholesterol. Use of triglyceride levels in determining LDL size.

  • Low Fat Diets.  // Pediatrics for Parents;2001, Vol. 19 Issue 9, p10 

    Examines the low fat diet for children with high lower-density lipoprotein cholesterol levels in the United States. Effect of the diet on the growth, development and maturation of children; Efficacy of the diet; Reliability of the diet for growing children with elevated levels of low density...

  • Conclusions of the Optimal Lean Diet Study go beyond the data. Bernstein, Adam M.; Willett, Walter C.; Roussell, Michael; Kris-Etherton, Penny // American Journal of Clinical Nutrition;May2012, Vol. 95 Issue 5, p1294 

    A letter to the editor is presented in response to an article by M. A. Roussell and colleagues titled "Beef in an Optimal Lean Diet Study: effects on lipids, lipoproteins, and apolipoproteins" published in the January 2012 issue of the Journal.

  • Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Jones, M L; Martoni, C J; Prakash, S // European Journal of Clinical Nutrition;Nov2012, Vol. 66 Issue 11, p1234 

    Background/Objectives:The percentage of hypercholesterolemic individuals not reaching their LDL-cholesterol (LDL-C) goal remains high and additional therapeutic strategies should be evaluated. The objective of this study was to evaluate the cholesterol-lowering efficacy and mechanism of action...

  • Acute Sterol O-Acyltransferase 2 (SOAT2) Knockdown Rapidly Mobilizes Hepatic Cholesterol for Fecal Excretion. Marshall, Stephanie M.; Gromovsky, Anthony D.; Kelley, Kathryn L.; Davis, Matthew A.; Wilson, Martha D.; Lee, Richard G.; Crooke, Rosanne M.; Graham, Mark J.; Rudel, Lawrence L.; Brown, J. Mark; Temel, Ryan E. // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    The primary risk factor for atherosclerotic cardiovascular disease is LDL cholesterol, which can be reduced by increasing cholesterol excretion from the body. Fecal cholesterol excretion can be driven by a hepatobiliary as well as a non-biliary pathway known as transintestinal cholesterol efflux...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics